Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Charlotta Grånäs"'
Autor:
Filippo Magaraci, Thomas Coulter, Jakob Felding, Serge G. Reignier, Christian Krog-Jensen, Christian A.G.N. Montalbetti, Muhammed Kamal Uddin, Charlotta Grånäs
Publikováno v:
Tetrahedron Letters. 47:5973-5975
We have developed synthetic protocols to generate 2-alkyl, 2-aryl and 2-acetylenyl substituted 4,6-diamino-1,3,5-triazines from the corresponding 2-chloro compound.
Autor:
Birgitte Bruun Rasmussen, Elisabeth D. Galsgaard, Louise Maymann Rasmussen, Charlotta Grånäs Folkesson, Martin W. Berchtold, Leif Christensen, Svetlana Panina
Publikováno v:
The Journal of endocrinology. 201(1)
The pituitary hormone PRL is involved in tumorigenesis in rodents and humans. PRL promotes proliferation, survival and migration of cancer cells acting via the PRL receptor (PRLR). Aiming to perform a large-scale immunohistochemical (IHC) screening o
Autor:
Thomas Stephen Coulter, Serge G. Reignier, Christian A.G.N. Montalbetti, Charlotta Grånäs, Steven Butcher, Christian Krog-Jensen, Muhammed Kamal Uddin, Jakob Felding
Publikováno v:
Bioorganicmedicinal chemistry letters. 17(10)
Syntheses and structure-antiproliferative relationship for oxyphenisatin analogues are described. The cell proliferation data showed that the presence of substituents (especially F, Cl, Me, CF(3), and OMe) in the 6- and 7-position of oxyphenisatin ma
Autor:
Charlotta Grånäs, Morten Praestegaard, Viggo Linde, Søren Jensby Nielsen, Frosty Loechel, Betina Kerstin Lundholt, Sara Petersen Bjørn, Eva-Maria Damsgaard Nielsen, Hans-Christian Pedersen, Christian Krogh-Jensen
Publikováno v:
Journal of biomolecular screening. 11(4)
The RAS-mitogen-activated protein kinase (MAPK) signaling pathway has a central role in regulating the proliferation and survival of both normal and tumor cells. This pathway has been 1 focus area for the development of anticancer drugs, resulting in
Publikováno v:
The Journal of biological chemistry. 279(5)
Recently we showed evidence that mutation of Tyr-335 to Ala (Y335A) in the human dopamine transporter (hDAT) alters the conformational equilibrium of the transport cycle. Here, by substituting, one at a time, 16 different bulky or charged intracellul
Publikováno v:
The Journal of biological chemistry. 278(7)
The structural basis of phosphorylation and its putative role in internalization were investigated in the human dopamine transporter (hDAT). Activation of protein kinase C (PKC) was achieved either directly by treatment with 4-alpha-phorbol 12-myrist
Publikováno v:
European journal of pharmacology. 421(2)
The antagonist radioligand [ 3 H]GR125743 and the agonist radioligand [ 3 H]5-HT were used to investigate the pharmacological characteristics of the G protein uncoupled agonist low-affinity and G protein coupled agonist high-affinity conformations of
Autor:
Dan Larhammar, Charlotta Grånäs
Publikováno v:
European journal of pharmacology. 380(2-3)
Site-directed mutagenesis of the human 5-HT1B receptor was performed to investigate the role of the amino acid residues cysteine 326 and tryptophan 327 in transmembrane region VI and aspartic acid 352 in transmembrane region VII in ligand binding. Bi
Publikováno v:
Journal of receptor and signal transduction research. 18(4-6)
We have used a combination of sequence comparisons, computer-based modeling and site-directed mutagenesis to investigate the molecular interactions involved in ligand binding and signal transduction of the human 5-HT1B receptor. Two amino acid residu
Publikováno v:
European journal of pharmacology. 349(2-3)
Site-directed mutagenesis was used to investigate the molecular interactions involved in ligand binding to the human 5-HT1B receptor. Six mutants were constructed at four positions and expressed in Chinese hamster ovary cells. Substitution of the ami